;

Articles Not Curated - Drug Studies-in vitro
Last updated: 2024 Jul 18
Total hit(s): 1132
S.No.
1
38086763
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
J Enzyme Inhib Med Chem
2024 Dec
8.6
1
2
38916498
"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.
Emerg Microbes Infect
2024 Dec
5.84
1
3
39522531
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC.
Lancet Infect Dis
2024 Nov 7
21.77
1
4
39522287
Dexamethasone-loaded chitosan-decorated PLGA nanoparticles: A step forward in attenuating the COVID-19 cytokine storm?
Colloids Surf B Biointerfaces
2024 Nov 5
1
5
39541564
Discovery of Chalcone Derivatives as Bifunctional Molecules with Anti-SARS-CoV-2 and Anti-inflammatory Activities.
J Nat Prod
2024 Nov 14
1
6
39535926
AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors.
J Chem Inf Model
2024 Nov 13
4.04
1
7
39102773
Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to block hACE2 and spike interaction.
Biosens Bioelectron
2024 Nov 1
9.52
1
8
39545673
Analysis of Nirmatrelvir Entry into Pulmonary Lining Fluid in Patients with COVID-19: A Unique Perspective to Explore and Understand the Target Plasma Concentration of 292 ng/mL in Antiviral Activity.
Immun Inflamm Dis
2024 Nov
2.28
1
9
39424074
Replication capacity and susceptibility of nirmatrelvir-resistant mutants to next-generation Mpro inhibitors in a SARS-CoV-2 replicon system.
Antiviral Res
2024 Nov
4.12
1
10
39379362
Coronavirus envelope protein activates TMED10-mediated unconventional secretion of inflammatory factors.
Nat Commun
2024 Oct 8
11.8
1
11
39398138
Inhibition of the SARS-CoV-2 Non-structural Protein 5 (NSP5) Protease by Nitrosocarbonyl-Bases Small Molecules.
ACS Omega
2024 Oct 8
2.55
1
12
39383977
Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2.
Eur J Pharm Biopharm
2024 Oct 7
1
13
39470901
IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.
Discov Oncol
2024 Oct 29
1
14
39468199
A single-center analysis of clonal transmission of carbapenem-resistant Acinetobacter baumannii among intensive care unit patients during the COVID-19 pandemic.
Sci Rep
2024 Oct 29
4.12
1
15
39414952
A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective.
Sci Rep
2024 Oct 16
4.12
1
16
39423875
Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial.
J Infect
2024 Oct 16
5.1
1
17
39415027
Immunomodulatory effect of IFN-gamma licensed adipose-mesenchymal stromal cells in an in vitro model of inflammation generated by SARS-CoV-2 antigens.
Sci Rep
2024 Oct 16
4.12
1
18
39387584
Mutation of a highly conserved isoleucine residue in loop 2 of several beta-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.
J Virol
2024 Oct 10
4.16
2
19
39357326
Identification of nitrile-containing isoquinoline-related natural product derivatives as coronavirus entry inhibitors in silico and in vitro.
Biomed Pharmacother
2024 Oct 1
3.83
1
20
39373132
Detection of Neutralizing Antibodies in Serum Samples Using a SARS-CoV-2 Pseudotyped Virus Assay.
Curr Protoc
2024 Oct
1
21
39400381
The SARS-unique domain (SUD) of SARS-CoV-2 nsp3 protein inhibits the antiviral immune responses through the NF-kappaB pathway.
J Med Virol
2024 Oct
2.07
1
22
39031747
Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS-CoV-2 by Use of Molecular Modelling and In Vitro Determination Approaches.
ChemistryOpen
2024 Oct
1
23
39386278
Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023.
Can Commun Dis Rep
2024 Oct
- n/a -
1
24
39246209
Phytoconstituents as modulator of inflammatory pathways for COVID-19: A comprehensive review and recommendations.
Phytother Res
2024 Sep 9
7.5
1
25
39240093
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice.
Antimicrob Agents Chemother
2024 Sep 6
4.68
1